Abstract
Hepatitis E is a globally distributed human disease caused by hepatitis E virus (HEV). In Europe, it spreads through undercooked pork meat or other products and with blood components through transfusions. There are no approved or golden standard serologic systems for HEV diagnostics. Commercially available HEV tests often provide inconsistent results which may differ among the assays. In this study, we describe generation in yeast and characterization of HEV genotype 3 (HEV-3) and rat HEV capsid proteins self-assembled into virus-like particles (VLPs) and the development of HEV-specific monoclonal antibodies (MAbs). Full-length HEV-3 and rat HEV capsid proteins and their truncated variants comprising amino acids (aa) 112-608 were produced in yeast S. cerevisiae. The yeast-expressed rat HEV capsid protein was found to be glycosylated. The full-length HEV-3 capsid protein and both full-length and truncated rat HEV capsid proteins were capable to self-assemble into VLPs. All recombinant proteins contained HEV genotype-specific linear epitopes and cross-reactive conformational epitopes recognized by serum antibodies from HEV-infected reservoir animals. Two panels of MAbs against HEV-3 and rat HEV capsid proteins were generated. Their cross-reactivity pattern was investigated by Western blot, ELISA, and immunofluorescence assay on HEV-3-infected cell cultures. The analysis revealed cross-reactive, genotype-specific, and virus-reactive MAbs. MAb epitopes were localized within S, M, and P domains of HEV-3 and rat HEV capsid proteins. Yeast-generated recombinant VLPs of HEV-3 and rat HEV capsid proteins and HEV-specific MAbs might be employed to develop novel HEV detection systems.
Similar content being viewed by others
References
Aggarwal R (2012) Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 10(1):24–33. https://doi.org/10.1038/nrgastro.2012.187
Bouwknegt M, Lodder-Verschoor F, van der Poel WHM, Rutjes SA, de Roda Husman AM (2007) Hepatitis E virus RNA in commercial porcine livers in The Netherlands. J Food Prot 70(12):2889–2895. https://doi.org/10.4315/0362-028X-70.12.2889
Cao D, Meng X-J (2012) Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect 1(8):e17. https://doi.org/10.1038/emi.2012.7
Dremsek P, Joel S, Baechlein C, Pavio N, Schielke A, Ziller M, Dürrwald R, Renner C, Groschup MH, Johne R, Krumbholz A, Ulrich RG (2013) Hepatitis E virus seroprevalence of domestic pigs in Germany determined by a novel in-house and two reference ELISAs. J Virol Methods 190(1-2):11–16. https://doi.org/10.1016/j.jviromet.2013.03.010
Dremsek P, Wenzel JJ, Johne R, Ziller M, Hofmann J, Groschup MH, Werdermann S, Mohn U, Dorn S, Motz M, Mertens M, Jilg W, Ulrich RG (2012) Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs. Med Microbiol Immunol 201(2):189–200. https://doi.org/10.1007/s00430-011-0221-2
Faber MS, Wenzel JJ, Jilg W, Thamm M, Höhle M, Stark K (2012) Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis 18(10):1654–1657. https://doi.org/10.3201/eid1810.111756
Gu Y, Tang X, Zhang X, Song C, Zheng M, Wang K, Zhang J, Ng M-H, Hew C-L, Li S, Xia N, Sivaraman J (2015) Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res 25(5):604–620. https://doi.org/10.1038/cr.2015.34
Guu TSY, Liu Z, Ye Q, Mata DA, Li K, Yin C, Zhang J, Tao YJ (2009) Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A 106(31):12992–12997. https://doi.org/10.1073/pnas.0904848106
Hartl J, Otto B, Madden R, Webb G, Woolson K, Kriston L, Vettorazzi E, Lohse A, Dalton H, Pischke S (2016) Hepatitis E Seroprevalence in Europe: a meta-analysis. Viruses 8(8):211. https://doi.org/10.3390/v8080211
He J, Kuschner RA, Dewar V, Voet P, Asher LV, Vaughn DW (2007) Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity. J Biomed Sci 14(5):555–563. https://doi.org/10.1007/s11373-007-9172-4
Johne R, Heckel G, Plenge-Bönig A, Kindler E, Maresch C, Reetz J, Schielke A, Ulrich RG (2010) Novel hepatitis E virus genotype in Norway rats, Germany. Emerg Infect Dis 16(9):1452–1455. https://doi.org/10.3201/eid1609.100444
Johne R, Trojnar E, Filter M, Hofmann J (2016) Thermal stability of hepatitis E virus as estimated by a cell culture method. Appl Environ Microbiol 82(14):4225–4231. https://doi.org/10.1128/AEM.00951-16
Khuroo MS, Khuroo MS (2016) Hepatitis E: an emerging global disease—from discovery towards control and cure. J Viral Hepat 23(2):68–79. https://doi.org/10.1111/jvh.12445
Khuroo MS, Khuroo MS, Khuroo NS (2016) Hepatitis E: discovery, global impact, control and cure. World J Gastroenterol 22(31):7030–7045. https://doi.org/10.3748/wjg.v22.i31.7030
Kobayashi T, Takahashi M, Tanggis M, Jirintai S, Nagashima S, Nishizawa T, Okamoto H (2016) Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: an evaluation of their neutralizing activity in a cell culture system. J Virol Methods 233:78–88. https://doi.org/10.1016/j.jviromet.2016.03.004
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495–497. https://doi.org/10.1038/256495a0
Kucinskaite I, Juozapaitis M, Serva A, Zvirbliene A, Johnson N, Staniulis J, Fooks AR, Müller T, Sasnauskas K, Ulrich RG (2007) Antigenic characterisation of yeast-expressed lyssavirus nucleoproteins. Virus Genes 35(3):521–529. https://doi.org/10.1007/s11262-007-0127-7
Kupferschmidt K (2016) Europe’s new hepatitis problem. Science (80-):353:862–863
Lee G-H, Tan B-H, Chi-Yuan Teo E, Lim S-G, Dan Y-Y, Wee A, Kim Aw PP, Zhu Y, Hibberd ML, Tan C-K, Purdy MA, Teo C-G (2016) Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology 150(2):355–357.e3. https://doi.org/10.1053/j.gastro.2015.10.048
Li S-W, Zhang J, He Z-Q, Gu Y, Liu R-S, Lin J, Chen Y-X, Ng M-H, Xia N-S (2005a) Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 280(5):3400–3406. https://doi.org/10.1074/jbc.M410361200
Li S, Tang X, Seetharaman J, Yang C, Gu Y, Zhang J, Du H, Shih JWK, Hew C-L, Sivaraman J, Xia N (2009) Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus–host interaction. PLoS Pathog 5(8):e1000537. https://doi.org/10.1371/journal.ppat.1000537
Li SW, Zhang J, Li YM, SH O, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH, Xia NS (2005b) A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23(22):2893–2901. https://doi.org/10.1016/j.vaccine.2004.11.064
Li T-C, Yamakawa Y, Suzuki K, Tatsumi M, Azeez Razak MA, Uchida T, Takeda N, Miyamura T (1997) Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 71(10):7207–7213
Li T-C, Yoshimatsu K, Yasuda SP, Arikawa J, Koma T, Kataoka M, Ami Y, Suzaki Y, Mai LTQ, Hoa NT, Yamashiro T, Hasebe F, Takeda N, Wakita T (2011) Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses. J Gen Virol 92(12):2830–2837. https://doi.org/10.1099/vir.0.034835-0
Liang J-H, Dai X, Dong C, Meng J-H (2010) A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus. Int J Mol Sci 11(8):2962–2975. https://doi.org/10.3390/ijms11082962
Meng J, Dai X, Chang JC, Lopareva E, Pillot J, Fields HA, Khudyakov YE (2001) Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288(2):203–211. https://doi.org/10.1006/viro.2001.1093
Mori Y, Matsuura Y (2011) Structure of hepatitis E viral particle. Virus Res 161(1):59–64. https://doi.org/10.1016/j.virusres.2011.03.015
Nan Y, Zhang Y-J (2016) Molecular biology and infection of hepatitis E virus. Front Microbiol 7:1419. https://doi.org/10.3389/fmicb.2016.01419
Packer NH, Ball MS, Devine PL, Patton WF (2009) Detection of glycoproteins in gels and blots. Protein Protoc Handbook:555–568. https://doi.org/10.1385/1-59259-169-8:761
Riddell MA, Li F, Anderson DA (2000) Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J Virol 74(17):8011–8017. https://doi.org/10.1128/JVI.74.17.8011-8017.2000
Ryll R, Bernstein S, Heuser E, Schlegel M, Dremsek P, Zumpe M, Wolf S, Pépin M, Bajomi D, Müller G, Heiberg A-C, Spahr C, Lang J, Groschup MH, Ansorge H, Freise J, Guenther S, Baert K, Ruiz-Fons F, Pikula J, Knap N, Tsakmakidis Ι, Dovas C, Zanet S, Imholt C, Heckel G, Johne R, Ulrich RG (2017) Detection of rat hepatitis E virus in wild Norway rats (Rattus norvegicus) and black rats (Rattus rattus) from 11 European countries. Vet Microbiol 208:58–68. https://doi.org/10.1016/j.vetmic.2017.07.001
Samuel D, Sasnauskas K, Jin L, Beard S, Zvirbliene A, Gedvilaite A, Cohen B (2002) High level expression of recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology. J Med Virol 66(1):123–130. https://doi.org/10.1002/jmv.2120
Sasnauskas K, Buzaite O, Vogel F, Jandrig B, Razanskas R, Staniulis J, Scherneck S, Krüger DH, Ulrich R (1999) Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol Chem 380(3):381–386. https://doi.org/10.1515/BC.1999.050
Schielke A, Sachs K, Lierz M, Appel B, Jansen A, Johne R (2009) Detection of hepatitis E virus in wild boars of rural and urban regions in Germany and whole genome characterization of an endemic strain. Virol J 6(1):58. https://doi.org/10.1186/1743-422X-6-58
Schofield DJ, Glamann J, Emerson SU, Purcell RH (2000) Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 74(12):5548–5555. https://doi.org/10.1128/JVI.74.12.5548-5555.2000
Shimizu K, Hamaguchi S, Ngo CC, Li T-C, Ando S, Yoshimatsu K, Yasuda SP, Koma T, Isozumi R, Tsuda Y, Fujita H, Pham TT, MQ LE, Dang AD, Nguyen TQ, Yoshida L-M, Ariyoshi K, Arikawa J (2016) Serological evidence of infection with rodent-borne hepatitis E virus HEV-C1 or antigenically related virus in humans. J Vet Med Sci 78(11):1677–1681. https://doi.org/10.1292/jvms.16-0200
Smith DB, Simmonds P, International Committee on Taxonomy of Viruses Hepeviridae Study Groupmembers of the IC on the T of VHS, Jameel S, Emerson SU, Harrison TJ, Meng X-J, Okamoto H, Van der Poel WHM, Purdy MA (2014) Consensus proposals for classification of the family Hepeviridae. J Gen Virol 95(Pt_10):2223–2232. https://doi.org/10.1099/vir.0.068429-0
Sommerkorn FM, Schauer B, Schreiner T, Fickenscher H, Krumbholz A (2017) Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany. Med Microbiol Immunol 206(3):277–286. https://doi.org/10.1007/s00430-017-0503-4
Takahashi M, Hoshino Y, Tanaka T, Takahashi H, Nishizawa T, Okamoto H (2008) Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system. Arch Virol 153(4):657–666. https://doi.org/10.1007/s00705-008-0045-6
Tamošiūnas PL, Simutis K, Kodzė I, Firantienė R, Emužytė R, Petraitytė-Burneikienė R, Žvirblienė A, Sasnauskas K (2013) Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum. Intervirology 56(5):271–277. https://doi.org/10.1159/000353112
Tang Z-M, Tang M, Zhao M, Wen G-P, Yang F, Cai W, Wang S-L, Zheng Z-Z, Xia N-S (2015) A novel linear neutralizing epitope of hepatitis E virus. Vaccine 33(30):3504–3511. https://doi.org/10.1016/j.vaccine.2015.05.065
Wacheck S, Werres C, Mohn U, Dorn S, Soutschek E, Fredriksson-Ahomaa M, Märtlbauer E (2012) Detection of IgM and IgG against hepatitis E virus in serum and meat juice samples from pigs at slaughter in Bavaria, Germany. Foodborne Pathog Dis 9(7):655–660. https://doi.org/10.1089/fpd.2012.1141
Wei M, Zhang X, Yu H, Tang Z-M, Wang K, Li Z, Zheng Z, Li S, Zhang J, Xia N, Zhao Q (2014) Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes. Vaccine 32(24):2859–2865. https://doi.org/10.1016/j.vaccine.2014.02.025
Wenzel JJ, Preiß J, Schemmerer M, Huber B, Plentz A, Jilg W (2011) Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol 52(1):50–54. https://doi.org/10.1016/j.jcv.2011.06.006
Widén F, Ayral F, Artois M, Olofson A-S, Lin J (2014) PCR detection and analyzis of potentially zoonotic Hepatitis E virus in French rats. Virol J 11(1):90. https://doi.org/10.1186/1743-422X-11-90
Wilson M, Nakane P (1978) Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. In: Knapp W, Holubar K, Wick G (eds) Immunofluorescence and related techniques. Elsevier, Amsterdam
Woo PCY, Lau SKP, Teng JLL, Tsang AKL, Joseph M, Wong EYM, Tang Y, Sivakumar S, Xie J, Bai R, Wernery R, Wernery U, Yuen K-Y (2014) New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis 20(6):1044–1048. https://doi.org/10.3201/eid2006.140140
Xing L, Kato K, Li T, Takeda N, Miyamura T, Hammar L, Cheng RH (1999) Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology 265(1):35–45. https://doi.org/10.1006/viro.1999.0005
Xing L, Li T-C, Mayazaki N, Simon MN, Wall JS, Moore M, Wang C-Y, Takeda N, Wakita T, Miyamura T, Cheng RH (2010) Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 285(43):33175–33183. https://doi.org/10.1074/jbc.M110.106336
Zhang H, Dai X, Shan X, Meng J (2009) Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4. Virus Res 142(1-2):140–143. https://doi.org/10.1016/j.virusres.2009.02.002
Zhang J, Gu Y, Ge SX, Li SW, He ZQ, Huang GY, Zhuang H, Ng MH, Xia NS (2005) Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23(22):2881–2892. https://doi.org/10.1016/j.vaccine.2004.11.065
Zhou Y-H, Purcell RH, Emerson SU (2004) An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22(20):2578–2585. https://doi.org/10.1016/j.vaccine.2003.12.017
Zvirbliene A, Pleckaityte M, Lasickiene R, Kucinskaite-Kodze I, Zvirblis G (2010) Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytolytic activity. Toxicon 56(1):19–28. https://doi.org/10.1016/j.toxicon.2010.03.007
Acknowledgments
We thank Marius Jasiulionis from the Nature Research Center (Vilnius, Lithuania) who provided wild rat samples.
Funding
This research was funded by the Lithuanian Science Council, Grant No. MIP-039/2015.
Author information
Authors and Affiliations
Contributions
I.K.-K. and M.S. conceived/designed the experiments, analyzed the data, and wrote the paper; M.S., P.L.T, R.P.B., and R.J. performed the research; A.Z., R.J., and R.G.U. contributed materials/analysis tools and revised the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Animal welfare
All applicable institutional, national, and international guidelines for the care and use of experimental animals were followed. The mice were used under the license no. LT 59-902, permission no. 184 for breeding of experimental mice, and permission no. 209 for generation of polyclonal and monoclonal antibodies obtained from the State Food and Veterinary Service, Vilnius, Lithuania.
Electronic supplementary material
ESM 1
(PDF 298kb)
Rights and permissions
About this article
Cite this article
Simanavicius, M., Tamosiunas, P.L., Petraityte-Burneikiene, R. et al. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles. Appl Microbiol Biotechnol 102, 185–198 (2018). https://doi.org/10.1007/s00253-017-8622-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-017-8622-9